As documented by the FDA, practices such as taking a higher amount of the drug in a single dose, taking doses more frequently, or increasing the amount of the drug more quickly can cause serious gastrointestinal problems, including nausea, vomiting, diarrhea, and abdominal pain
Meneilly GS, Roy-Duval C, Alawi H, et al
Both are in late-stage clinical development and both add glucagon receptor (GCGR) activation on top of the GLP-1 backbone
Local clinics add a physical exam on-site
Novo Nordisk asserts that Ozempics safety is thoroughly documented, with all potential side effects duly reported in compliance with regulatory standards
Semaglutide vs phentermine at a glance The table makes the trade-off legible: semaglutide wins on magnitude and durability of weight loss and on long-term indication